Moderna, Inc. officer Stephen Hoge is set to sell 254 shares of the company's common stock on 08/12/2024, with an aggregate market value of $21,362.59. The shares were acquired on 08/09/2024 as part of a restricted stock vesting and are considered compensation from the issuer. This transaction follows a series of sales over the past three months, where a total of 45,680 shares were sold for gross proceeds of $5,898,530.11.

Moderna, Inc. officer Stephen Hoge is set to sell 254 shares of the company's common stock on 08/12/2024, with an aggregate market value of $21,362.59. The shares were acquired on 08/09/2024 as part of a restricted stock vesting and are considered compensation from the issuer. This transaction follows a series of sales over the past three months, where a total of 45,680 shares were sold for gross proceeds of $5,898,530.11.